| 1 | it is important to | | | | | | | 28 | 0.66% |
| 2 | seek immediate medical attention | | | | | | | 6 | 0.14% |
| 3 | increase the risk of | | | | | | | 6 | 0.14% |
| 4 | is important to inform | | | | | | | 5 | 0.12% |
| 5 | is important to take | | | | | | | 5 | 0.12% |
| 6 | it is crucial to | | | | | | | 5 | 0.12% |
| 7 | side effects it is | | | | | | | 5 | 0.12% |
| 8 | the growth and spread | | | | | | | 4 | 0.09% |
| 9 | is commonly prescribed for | | | | | | | 4 | 0.09% |
| 10 | inform your healthcare provider | | | | | | | 4 | 0.09% |
| 11 | used to treat various | | | | | | | 4 | 0.09% |
| 12 | growth and spread of | | | | | | | 4 | 0.09% |
| 13 | healthcare provider about all | | | | | | | 4 | 0.09% |
| 14 | your healthcare provider about | | | | | | | 4 | 0.09% |
| 15 | the full course of | | | | | | | 4 | 0.09% |
| 16 | with your healthcare provider | | | | | | | 4 | 0.09% |
| 17 | medications you are taking | | | | | | | 4 | 0.09% |
| 18 | your healthcare provider for | | | | | | | 4 | 0.09% |
| 19 | even if symptoms improve | | | | | | | 4 | 0.09% |
| 20 | full course of treatment | | | | | | | 4 | 0.09% |
| 21 | and spread of bacteria | | | | | | | 4 | 0.09% |
| 22 | important to take bactrim | | | | | | | 4 | 0.09% |
| 23 | inhibit the growth and | | | | | | | 4 | 0.09% |
| 24 | vary depending on the | | | | | | | 3 | 0.07% |
| 25 | the guidance of a | | | | | | | 3 | 0.07% |
| 26 | of bacteria‚ making it | | | | | | | 3 | 0.07% |
| 27 | taking bactrim sulfamethoxazole‚ it | | | | | | | 3 | 0.07% |
| 28 | sulfamethoxazole‚ it is important | | | | | | | 3 | 0.07% |
| 29 | prescribed for urinary tract | | | | | | | 3 | 0.07% |
| 30 | if you experience any | | | | | | | 3 | 0.07% |
| 31 | form and should be | | | | | | | 3 | 0.07% |
| 32 | important to inform your | | | | | | | 3 | 0.07% |
| 33 | to follow the prescribed | | | | | | | 3 | 0.07% |
| 34 | healthcare provider for further | | | | | | | 3 | 0.07% |
| 35 | the risk of side | | | | | | | 3 | 0.07% |
| 36 | contact your healthcare provider | | | | | | | 3 | 0.07% |
| 37 | even if symptoms improve‚ | | | | | | | 3 | 0.07% |
| 38 | commonly prescribed for urinary | | | | | | | 3 | 0.07% |
| 39 | it is essential to | | | | | | | 3 | 0.07% |
| 40 | guidance of a healthcare | | | | | | | 3 | 0.07% |